LifeStance Health Group, Inc. $LFST Shares Sold by Algert Global LLC

Algert Global LLC lowered its stake in shares of LifeStance Health Group, Inc. (NASDAQ:LFST) by 30.6% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 272,910 shares of the company’s stock after selling 120,540 shares during the quarter. Algert Global LLC’s holdings in LifeStance Health Group were worth $2,923,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in LFST. Larson Financial Group LLC raised its position in LifeStance Health Group by 19,952.6% during the fourth quarter. Larson Financial Group LLC now owns 3,810 shares of the company’s stock worth $27,000 after acquiring an additional 3,791 shares during the last quarter. KBC Group NV bought a new stake in shares of LifeStance Health Group during the 1st quarter worth about $29,000. EverSource Wealth Advisors LLC increased its position in shares of LifeStance Health Group by 359.1% in the first quarter. EverSource Wealth Advisors LLC now owns 6,909 shares of the company’s stock worth $44,000 after acquiring an additional 5,404 shares in the last quarter. Bayesian Capital Management LP acquired a new position in LifeStance Health Group during the second quarter worth $52,000. Finally, PNC Financial Services Group Inc. lifted its position in shares of LifeStance Health Group by 615.3% in the 1st quarter. PNC Financial Services Group Inc. now owns 9,285 shares of the company’s stock worth $59,000 after acquiring an additional 7,987 shares during the period. 85.50% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

LFST has been the topic of several recent analyst reports. The Goldman Sachs Group began coverage on LifeStance Health Group in a report on Friday, June 5th. They set a “neutral” rating and a $9.00 target price on the stock. Canaccord Genuity Group increased their target price on shares of LifeStance Health Group from $11.00 to $13.00 and gave the company a “buy” rating in a report on Tuesday, July 21st. Barclays boosted their target price on LifeStance Health Group from $9.00 to $13.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 14th. KeyCorp upped their price objective on LifeStance Health Group from $11.00 to $13.00 and gave the stock an “overweight” rating in a research note on Monday, July 13th. Finally, JPMorgan Chase & Co. lifted their price target on shares of LifeStance Health Group from $9.00 to $13.00 and gave the company a “neutral” rating in a research report on Friday, August 14th. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat.com, LifeStance Health Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $12.38.

Insider Buying and Selling at LifeStance Health Group

In other news, COO Lisa K. Miller sold 47,912 shares of LifeStance Health Group stock in a transaction on Monday, August 10th. The shares were sold at an average price of $10.85, for a total value of $519,845.20. Following the completion of the sale, the chief operating officer owned 281,289 shares in the company, valued at $3,051,985.65. The trade was a 14.55% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, major shareholder Tpg Gp A, Llc sold 13,643,207 shares of the business’s stock in a transaction on Monday, August 10th. The shares were sold at an average price of $10.62, for a total transaction of $144,890,858.34. Following the sale, the insider owned 98,101,407 shares of the company’s stock, valued at $1,041,836,942.34. This trade represents a 12.21% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 14,629,850 shares of company stock worth $154,952,012 in the last three months. 3.50% of the stock is currently owned by company insiders.

LifeStance Health Group Trading Up 0.1%

Shares of NASDAQ LFST opened at $12.31 on Friday. LifeStance Health Group, Inc. has a 12 month low of $4.77 and a 12 month high of $12.97. The company has a quick ratio of 1.38, a current ratio of 1.38 and a debt-to-equity ratio of 0.18. The company has a market cap of $4.77 billion, a price-to-earnings ratio of 94.70 and a beta of 1.14. The business has a fifty day simple moving average of $11.19 and a 200-day simple moving average of $8.60.

LifeStance Health Group (NASDAQ:LFST) last posted its earnings results on Thursday, August 6th. The company reported $0.06 earnings per share for the quarter, beating the consensus estimate of $0.03 by $0.03. LifeStance Health Group had a return on equity of 3.39% and a net margin of 3.19%.The company had revenue of $435.35 million for the quarter, compared to analyst estimates of $414.58 million. During the same period last year, the company earned ($0.01) earnings per share. The business’s revenue was up 26.1% compared to the same quarter last year. Sell-side analysts predict that LifeStance Health Group, Inc. will post 0.16 EPS for the current year.

LifeStance Health Group Profile

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.